Gesine B.
- Country
- Germany
- Department
- Universitätsklinikum Frankfurt, Medizinische Klinik II
Research Overview
- Evaluation of KITE-222 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications
- Evaluation of CPX-351 Versus Conventional Care Regimens Prior to Allogeneic Hematopoietic Cell Transplantation in High-Risk MDS and Oligoblastic AML Patients
Data & Insights
Has run more than one trial at 82 of 170 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various forms of blood cancers, with particular focus on acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and lymphomas.
- Acute and Chronic Leukemias
- B-Cell Lymphomas
- Myelodysplastic Syndromes
Their work encompasses both conventional and innovative therapeutic approaches for these conditions.
Stem Cell Transplantation
The investigator has extensive experience in allogeneic hematopoietic cell transplantation and its associated complications, including conditioning regimens and post-transplant care.
- Transplant Conditioning Protocols
- Graft versus Host Disease Management
- Post-transplant Complications
Their expertise includes novel approaches to improve transplant outcomes and reduce complications.
Cellular Therapies
The investigator focuses on developing and implementing advanced cellular therapies, including mesenchymal stromal cells and CAR-T cell treatments.
- Immunotherapy Approaches
- Cell-based Treatments
- Microbiome Therapeutics
Their work integrates innovative cellular approaches with established treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.